Read our UTI blog

NEW study highlights efficacy of ellura in reducing Catheter-Associated UTIs(CA-UTIs)

If you or someone you care for has limited mobility, requires a catheter or has a spinal cord injury, the risk of a UTI is substantially higher. A UTI is a complication caused by the bladder not emptying completely which leads to an overgrowth of bacteria in the urine. A new study with catheter-assisted patients has confirmed what our customers already know – ellura offers proven UTI protection!

Physicians from Weill Cornell Medical and Columbia Medical Centre in New York evaluated catheter-assisted patients with a previous history of UTIs to determine the benefits of once daily ellura over the course of 6 months. All patients participating in the study were UTI-free throughout the 6 months and no side effects were reported, further supporting the use of ellura for recurrent UTIs.

The study is a great addition to our already strong portfolio of published clinical evidence that the 36 mg PAC in ellura is a proven alternative to antibiotics for UTI prevention. Other supplements cannot compete when it comes to PAC content and anti-adhesion activity, which is supported by published research and thousands of physicians and customers that have seen for themselves the benefits of ellura!

Want to review the scientific details? See the study highlights below.

Study Highlights:

  • 22 patients with long-term indwelling catheters & recurrent symptomatic CA-UTIs were evaluated.
  • Once daily consumption of ellura containing 36 mg PAC for 6 months.
  • NO UTIs were reported over the 6 months. No side effects noted.
  • 28% reduction of antibiotic resistances was also noted, with the greatest reduction among tetracycline, levofloxacin and cefazolin.

Thomas, D., Chughtai B, et al. Weill Cornell Medicine. Cooper K, Columbia University Medical Center/New York Presbyterian Hospital. Jones D, Innovative Senior Center, NY. Can Urol Assoc J 2017;11(11):E421-4. 


Dr. Sophie Fletcher, urologist, discusses UTIs                                     

Does ellura really work?

I’ve seen a phenomenal response in patients who are taking ellura to reduce urinary tract infections. There have been studies that prove you need 36 mg PAC to prevent bacteria from attaching to the bladder wall and forming an infection- and only ellura offers that 36 mg PAC. I recommend it to nearly every patient with recurrent UTIs that come see me and I’ve seen hundreds of patients have successful experiences with ellura.

Who should take ellura?

I recommend it to almost all patients who have recurrent UTIs. I also recommend it to patients with catheters, kidney transplant recipients, and people with diabetes, prolapsed bladders and interstitial cystitis(IC). Because it doesn’t interfere with other medications and there aren’t any side effects, ellura is the most effective and safe way to manage recurrent UTIs without antibiotics.

Why not just take an antibiotic?

Bacterial resistance is such a huge issue worldwide for physicians right now. We are constantly trying to avoid antibacterial overuse. If we can present our patients with a natural supplement and keep them off antibiotics, that’s really phenomenal. Some of my patients have been on antibiotics for so long that they’ve developed an immunity to the effects of the antibiotics and are reaching the end of their options for treatment. Patients should be weary of low-dose antibiotics for UTI prevention because you could jeopardize your ability to treat UTIs (and other infections that use the same drug for treatment) in the future.